Search results
Results from the WOW.Com Content Network
[16] 2013 saw the company complete its highest number of acquisitions with Lotus Tissue Repair, Inc. (lead compound, ABH001), [17] SARcode Bioscience Inc., [18] with the last being ViroPharma. Shire changed the name of ViroPharma to Shire Viropharma Inc. upon acquisition and on their final day of trading the company was valued at $3.3 billion. [19]
ViroPharma Incorporated was a pharmaceutical company that developed and sold drugs that addressed serious diseases treated by physician specialists and in hospital settings. The company focused on product development activities on viruses and human disease , including those caused by cytomegalovirus (CMV) and hepatitis C virus (HCV) infections.
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
What: Shares of ViroPharma Inc. , a. Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to ...
Shire buys ViroPharma for $4.2 billionIrish pharmaceutical company Shire just announced that it will buy ViroPharma for Why You Should Keep an Eye on Shire, ViroPharma, and Novartis Today Skip to ...
Need help? Call us! 800-290-4726 Login / Join. Mail
SARcode Bioscience Inc (Acq 2013) ViroPharma (Founded 1994, Acq 2013) Lev Pharmaceuticals (Acq 2008) Fibrotech (Acq 2014) Lumena (Acq 2014) NPS Pharmaceuticals (Acq 2015) Meritage Pharma (Acq 2015) Foresight Biotherapeutics (Acq 2015) Dyax (Acq 2015) Baxalta (Acq 2016) PvP Biologics, Inc. (Acq 2020) Maverick Therapeutics, Inc. (Acq 2021)
For premium support please call: 800-290-4726 more ways to reach us